Key Metrics
CiteScore 

10.3
Eigenfactor 

0.005 - 0.01
H-Index 

97
Impact Factor 

5 - 10
SJR 

Q1Endocrinology

SNIP 

1.97
Recommended pre-submission checks
Powered by 

Topics Covered on Diabetes Technology and Therapeutics
Diabetes Technology and Therapeutics Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Diabetes Technology and Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Diabetes Technology and Therapeutics
Glycemic Outcomes and Device Engagement Over 18 Months Following Initiation of Two Different Automated Insulin Delivery Systems in American Youth With Type 1 Diabetes.
- 20 May 2026
- Diabetes technology & therapeutics
Real-World Total Daily Insulin Dose in over 14,000 Young Individuals with Type 1 Diabetes in the United States.
- 12 May 2026
- Diabetes technology & therapeutics
Real-World Ketone Testing Patterns Among People Using FreeStyle Libre.
- 11 May 2026
- Diabetes technology & therapeutics
Cardiovascular, Renal, and Hepatic Biomarkers Outside Guideline-Recommended Thresholds: Prevalence and Determinants in Type 1 Diabetes.
- 7 May 2026
- Diabetes technology & therapeutics
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.
- 28 Apr 2026
- Diabetes technology & therapeutics
Operational and Clinical Insights from a Fully Decentralized Clinical Study Evaluating Protocol Adherence, Participant Satisfaction, and Connected Device Data in Individuals with Type 2 Diabetes on Different Treatment Regimens.
- 17 Apr 2026
- Diabetes technology & therapeutics
Glycemic Outcomes and Device Engagement Over 18 Months Following Initiation of Two Different Automated Insulin Delivery Systems in American Youth With Type 1 Diabetes.
- 20 May 2026
- Diabetes technology & therapeutics
Real-World Total Daily Insulin Dose in over 14,000 Young Individuals with Type 1 Diabetes in the United States.
- 12 May 2026
- Diabetes technology & therapeutics
Real-World Ketone Testing Patterns Among People Using FreeStyle Libre.
- 11 May 2026
- Diabetes technology & therapeutics
Cardiovascular, Renal, and Hepatic Biomarkers Outside Guideline-Recommended Thresholds: Prevalence and Determinants in Type 1 Diabetes.
- 7 May 2026
- Diabetes technology & therapeutics
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.
- 28 Apr 2026
- Diabetes technology & therapeutics
Operational and Clinical Insights from a Fully Decentralized Clinical Study Evaluating Protocol Adherence, Participant Satisfaction, and Connected Device Data in Individuals with Type 2 Diabetes on Different Treatment Regimens.
- 17 Apr 2026
- Diabetes technology & therapeutics